Your session is about to expire
← Back to Search
Abatacept for Graft-versus-Host Disease
Study Summary
This trial is for people who are getting a stem cell transplant for certain blood cancers.
- Graft-versus-Host Disease
- Cancer
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2023 Phase 3 trial • 613 Patients • NCT03086343Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Abatacept is typically given to patients for what reason?
"Abatacept is a medication used to treat rheumatoid arthritis. However, it can also be taken to ameliorate the symptoms of other conditions like psoriatic arthritis, polyarticular juvenile idiopathic arthritis, and severe juvenile idiopathic arthritis."
Does the data from this study corroborate other research on Abatacept?
"Abatacept was first studied in 2007 at University of Nebraska Medical Center. Since that time, there have been 2778 completed trials. As of now, 36 studies are actively recruiting new participants-- many of these taking place in Atlanta, Georgia."
Is this study taking place in many different hospitals across the state?
"Enrollment for this clinical trial is currently underway at 14 different centres, some of which are Emory University/Winship Cancer Center in Atlanta, UCSF Benioff Children's Hospital Oakland in Oakland and Children's Hospital Los Angeles in Los Angeles."
How many people are being given this medication as part of the research study?
"Unfortunately, this particular study has ceased looking for new participants. The last update to the trial was on August 2nd, 2021. However, there are 668 other trials currently underway for patients with malignancies and 36 more that use Abatacept as an intervention."
What have been the most serious side effects of Abatacept reported by patients?
"While Phase 2 trials are not as well studied as later phases, there is enough evidence to support the safety of Abatacept."
Are people with the target condition able to enroll in this trial currently?
"Unfortunately, this study is not recruiting patients at the moment. Although, it is worth noting that there are 704 other clinical trials with open enrollments. This particular study was first posted on February 1st 2013 and received its last update August 2nd 2021."
Share this study with friends
Copy Link
Messenger